📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Forward Pharma

1.1 - Company Overview

Forward Pharma Logo

Forward Pharma

Headquarter: Denmark
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biotechnology focused on the immunomodulatory compound dimethyl fumarate and derivatives for pharmaceutical drug applications to treat immune disorders such as multiple sclerosis and psoriasis; founded in 2005 and headquartered in Copenhagen, Denmark.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Forward Pharma

Grifols Logo

Grifols

HQ: Spain Website
  • Description: Provider of healthcare solutions operating in Bioscience, Hospital, and Diagnostic segments. The Bioscience segment engages in the research, development, production, and commercialization of plasma derivates. The Diagnostic segment focuses on researching, developing, manufacturing, and marketing diagnostics products.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Grifols company profile →
Step Pharma Logo

Step Pharma

HQ: France Website
  • Description: Provider of CTPS1 inhibition therapies, developing STP938, an orally bioavailable CTPS1 inhibitor in clinical development for treating blood cancers and potentially solid tumors. The approach targets the CTPS1 enzyme to inhibit a key step in nucleotide synthesis to treat various cancers.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Step Pharma company profile →
Medac Pharma Logo

Medac Pharma

HQ: United States Website
  • Description: Provider of healthcare products for rare diseases across rheumatology, auto-immune conditions, pediatrics, and specialty oncology. Offers therapies such as methotrexate formulations (Rasuvo auto-injector, Metoject pre-filled syringe) for rheumatoid arthritis and other auto-immune diseases; Rupall for allergies; IXINITY for Hemophilia B; Gleolan for glioma imaging; Trecondyv for transplant conditioning.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Medac Pharma company profile →
Sudo Biosciences Logo

Sudo Biosciences

HQ: United States Website
  • Description: Provider of TYK2 pseudokinase domain–targeting medicines, including a brain-penetrant TYK2 inhibitor for multiple sclerosis and neurodegenerative diseases, and a topical TYK2 inhibitor for psoriasis and other immune-mediated dermatologic conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sudo Biosciences company profile →
Sucampo Pharmaceuticals Logo

Sucampo Pharmaceuticals

HQ: United States Website
  • Description: Provider of specialized biopharmaceuticals addressing unmet medical needs, with marketed products AMITIZA for chronic constipation and IBS-C in adults and RESCULA in Japan for lowering intraocular pressure in glaucoma or ocular hypertension, and a late-stage pipeline including VTS-270 for Niemann-Pick Disease Type C and CPP-1X/sulindac for Familial Adenomatous Polyposis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Sucampo Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Forward Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Forward Pharma

2.2 - Growth funds investing in similar companies to Forward Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Forward Pharma

4.2 - Public trading comparable groups for Forward Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Forward Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Forward Pharma

What does Forward Pharma do?

Forward Pharma is a provider of biotechnology focused on the immunomodulatory compound dimethyl fumarate and derivatives for pharmaceutical drug applications to treat immune disorders such as multiple sclerosis and psoriasis; founded in 2005 and headquartered in Copenhagen, Denmark.

Who are Forward Pharma's competitors?

Forward Pharma's competitors and similar companies include Grifols, Step Pharma, Medac Pharma, Sudo Biosciences, and Sucampo Pharmaceuticals.

Where is Forward Pharma headquartered?

Forward Pharma is headquartered in Denmark.

How many employees does Forward Pharma have?

Forward Pharma has 1,000 employees 🔒.

When was Forward Pharma founded?

Forward Pharma was founded in 2010 🔒.

What sector and industry vertical is Forward Pharma in?

Forward Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Forward Pharma

Who are the top strategic acquirers in Forward Pharma's sector and industry

Top strategic M&A buyers and acquirers in Forward Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Forward Pharma?

Top strategic M&A buyers groups and sectors for Forward Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Forward Pharma's sector and industry vertical

Which are the top PE firms investing in Forward Pharma's sector and industry vertical?

Top PE firms investing in Forward Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Forward Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Forward Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Forward Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Forward Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Forward Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Forward Pharma?

The key public trading comparables and valuation benchmarks for Forward Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Forward Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Forward Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Forward Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Forward Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Forward Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Forward Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Forward Pharma